SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLN.L Regulatory News (SLN)

  • There is currently no data for SLN

Potential Offer

6 Sep 2010 15:14

RNS Number : 2239S
Silence Therapeutics PLC
06 September 2010
 



 

 

FOR IMMEDIATE RELEASE

 

Potential Offer

 

London, 6 September, 2010 - Silence Therapeutics plc (AIM: SLN) notes the recent share price movement and announces that it has received an approach which may or may not lead to an offer for the Company. A further announcement will be made in due course.

 

For further information, please contact:

 

Silence Therapeutics

Phil Haworth, CEO +1 (650) 855-1514

p.haworth@silence-therapeutics.com

NOMAD

Nomura Code Securities

Richard Potts / Jonathan Senior

+44 20 7776 1200

 

European media and investor enquiries:

M:Communications +44 20 7920 2342

Mary-Jane Elliott / Emma Thompson

 

US media and investor enquiries:

Vida Communication +44 (415) 675-7400

Tim Brons (media)

tbrons@vidacommunication.com 

or

Stephanie Diaz (investors)

sdiaz@vidacommunication.com

 

The City Code on Takeovers and Mergers (the "City Code")

 

1) Rule 2.10 of the City Code

 

In accordance with Rule 2.10 of the City Code, the Company confirms that it has 279,891,452 ordinary shares of 1p each in issue under the ISIN code GB0008433350.

 

2) Disclosure requirements of the Takeover Code (the "Code")

 

Under Rule 8.3(a) of the Code, any person who is interested in 1% or more of any class of relevant securities of an offeree company or of any paper offeror (being any offeror other than an offeror in respect of which it has been announced that its offer is, or is likely to be, solely in cash) must make an Opening Position Disclosure following the commencement of the offer period and, if later, following the announcement in which any paper offeror is first identified. An Opening Position Disclosure must contain details of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any paper offeror(s). An Opening Position Disclosure by a person to whom Rule 8.3(a) applies must be made by no later than 3.30 pm (London time) on the 10th business day following the commencement of the offer period and, if appropriate, by no later than 3.30 pm (London time) on the 10th business day following the announcement in which any paper offeror is first identified. Relevant persons who deal in the relevant securities of the offeree company or of a paper offeror prior to the deadline for making an Opening Position Disclosure must instead make a Dealing Disclosure.

 

Under Rule 8.3(b) of the Code, any person who is, or becomes, interested in 1% or more of any class of relevant securities of the offeree company or of any paper offeror must make a Dealing Disclosure if the person deals in any relevant securities of the offeree company or of any paper offeror. A Dealing Disclosure must contain details of the dealing concerned and of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any paper offeror, save to the extent that these details have previously been disclosed under Rule 8. A Dealing Disclosure by a person to whom Rule 8.3(b) applies must be made by no later than 3.30 pm (London time) on the business day following the date of the relevant dealing.

 

If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an offeree company or a paper offeror, they will be deemed to be a single person for the purpose of Rule 8.3.

 

Opening Position Disclosures must also be made by the offeree company and by any offeror and Dealing Disclosures must also be made by the offeree company, by any offeror and by any persons acting in concert with any of them (see Rules 8.1, 8.2 and 8.4). Details of the offeree and offeror companies in respect of whose relevant securities Opening Position Disclosures and Dealing Disclosures must be made can be found in the Disclosure Table on the Takeover Panel's website at www.thetakeoverpanel.org.uk, including details of the number of relevant securities in issue, when the offer period commenced and when any offeror was first identified. If you are in any doubt as to whether you are required to make an Opening Position Disclosure or a Dealing Disclosure, you should contact the Panel's Market Surveillance Unit on +44 (0)20 7638 0129.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
SPMZQLFBBKFBBBK
Date   Source Headline
24th Apr 20094:35 pmRNSPrice Monitoring Extension
1st Apr 20097:00 amPRNUnaudited Preliminary Results
30th Mar 200912:15 pmPRNNotice of Results
27th Mar 20094:40 pmRNSSecond Price Monitoring Extn
27th Mar 20094:35 pmRNSPrice Monitoring Extension
19th Mar 20091:22 pmPRNHolding(s) in Company
16th Feb 20093:37 pmPRNHolding(s) in Company
21st Jan 20097:00 amPRNStatement re Patent Update
19th Jan 20091:00 pmPRNHolding(s) in Company
15th Jan 20093:00 pmPRNTotal Voting Rights
15th Jan 20099:45 amPRNHolding(s) in Company
13th Jan 20094:36 pmRNSPrice Monitoring Extension
12th Jan 20097:00 amPRNStatement re Change of operating address
9th Jan 200911:20 amPRNStatement re Patent Grant
8th Jan 20092:21 pmPRNResearch Update
8th Jan 200912:03 pmPRNIssue of Equity
5th Jan 20094:40 pmRNSSecond Price Monitoring Extn
5th Jan 20094:35 pmRNSPrice Monitoring Extension
2nd Jan 20094:35 pmRNSPrice Monitoring Extension
31st Dec 200812:40 pmRNSSecond Price Monitoring Extn
31st Dec 200812:36 pmRNSPrice Monitoring Extension
31st Dec 20087:00 amPRNTotal Voting Rights
18th Dec 20084:35 pmRNSPrice Monitoring Extension
12th Dec 20084:40 pmRNSSecond Price Monitoring Extn
12th Dec 20084:36 pmRNSPrice Monitoring Extension
11th Dec 20087:10 amPRNHolding(s) in Company
10th Dec 20087:00 amPRNStatement re Patent Decision
5th Dec 200812:05 pmPRNIssue of Equity
4th Dec 20087:00 amPRNResearch Update
1st Dec 20087:00 amPRNResearch Update
18th Nov 20087:00 amPRNStatement re Patent Issue
13th Nov 20081:00 pmPRNHolding(s) in Company
10th Nov 20084:44 pmRNSSecond Price Monitoring Extn
10th Nov 20084:37 pmRNSPrice Monitoring Extension
29th Oct 200811:00 amPRNHolding(s) in Company
27th Oct 20089:45 amPRNDirector/PDMR Shareholding
22nd Oct 200812:51 pmPRNDirector/PDMR Shareholding
22nd Oct 20087:00 amPRNDirector/PDMR Shareholding
17th Oct 20083:34 pmPRNAGM Statement
8th Oct 200810:15 amPRNHolding(s) in Company
26th Sep 20085:05 pmPRNDirector/PDMR Shareholding
26th Sep 200811:55 amPRNStatement re Intellectual Property
25th Sep 20087:00 amPRNHalf-yearly Report
24th Sep 200811:40 amPRNHolding(s) in Company
29th Aug 200812:15 pmPRNHolding(s) in Company
26th Aug 20085:11 pmPRNHolding(s) in Company
7th Aug 20088:57 amPRNHolding(s) in Company
5th Aug 20082:00 pmPRNHolding(s) in Company
31st Jul 20087:00 amPRNStatement re Notice of Patent Allowance
30th Jul 20084:25 pmPRNStatement re Notice of Patent Allowance

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.